Vitamin D Deficiency Induces High Blood Pressure and Accelerates Atherosclerosis in Mice

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Weng, Sherry ^a   Sprague, Jennifer E ^a   Oh, Jisu ^a   Riek, Amy E ^a   Chin, Kathleen ^a   Garcia, Miguel ^a   Bernal Mizrachi, Carlos ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOENZYME; LOW DENSITY LIPOPROTEIN RECEPTOR; RENIN; SODIUM; VITAMIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA ATHEROSCLEROSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; FOAM CELL; HYPERTENSION; IN VIVO STUDY; LIPID DIET; MOUSE; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PLASMA RENIN ACTIVITY; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; VITAMIN D DEFICIENCY;

ANIMALS; AORTA, ABDOMINAL; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIET, HIGH-FAT; ENDOPLASMIC RETICULUM STRESS; HUMANS; HYPERTENSION; MACROPHAGES; MICE; MICE, KNOCKOUT; RECEPTORS, LDL; VITAMIN D; VITAMIN D DEFICIENCY;

MUS;

EID: 84872789087     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054625     Document Type: Article

References (70)

1. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, et al. (2012) American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr Pract 18Suppl 1: 1-78.
2. Kreisberg RA, Oberman A, (2002) Clinical review 141: lipids and atherosclerosis: lessons learned from randomized controlled trials of lipid lowering and other relevant studies. J Clin Endocrinol Metab 87: 423-437.
3. Rader DJ, Pure E, (2005) Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? Cell Metab 1: 223-230.
4. Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, et al. (2007) PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 6: 137-143.
5. Mantovani A, Garlanda C, Locati M, (2009) Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol 29: 1419-1423.
6. Martinez FO, Gordon S, Locati M, Mantovani A, (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177: 7303-7311.
7. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM, (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164: 6166-6173.
8. Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, et al. (2011) Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 123: 989-998.
9. Feig JE, Pineda-Torra I, Sanson M, Bradley MN, Vengrenyuk Y, et al. (2010) LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest 120: 4415-4424.
10. Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, et al. (2011) HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proceedings of the National Academy of Sciences of the United States of America 108: 7166-7171.
11. van Tits LJ, Stienstra R, van Lent PL, Netea MG, Joosten LA,et al. Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Kruppel-like factor 2. Atherosclerosis 214: 345-349.
12. Bories G, Caiazzo R, Derudas B, Copin C, Raverdy V, et al. (2012) Impaired alternative macrophage differentiation of peripheral blood mononuclear cells from obese subjects. Diab Vasc Dis Res 9: 189-195.
13. Chinetti-Gbaguidi G, Baron M, Bouhlel MA, Vanhoutte J, Copin C, et al. (2011) Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARgamma and LXRalpha pathways. Circ Res 108: 985-995.
14. Tabas I, (2010) The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ Res 107: 839-850.
15. Schaefer A, Magocsi M, Stocker U, Kosa F, Marquardt H, (1994) Early transient suppression of c-myb mRNA levels and induction of differentiation in Friend erythroleukemia cells by the [Ca2+]i-increasing agents cyclopiazonic acid and thapsigargin. J Biol Chem 269: 8786-8791.
16. Dickhout JG, Brooke H, Basseri S, Lhotak S, KS S, et al. (2008) Macrophage Differentiation Involves Activation of the Unfolded Protein Response. FASEB 22: 924.911.
17. Launay S, Gianni M, Kovacs T, Bredoux R, Bruel A, et al. (1999) Lineage-specific modulation of calcium pump expression during myeloid differentiation. Blood 93: 4395-4405.
18. Berridge MJ, (1995) Calcium signalling and cell proliferation. Bioessays 17: 491-500.
19. Zhou J, Lhotak S, Hilditch BA, Austin RC, (2005) Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 111: 1814-1821.
20. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, et al. (2003) The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 5: 781-792.
21. Myoishi M, Hao H, Minamino T, Watanabe K, Nishihira K, et al. (2007) Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation 116: 1226-1233.
22. Devries-Seimon T, Li Y, Yao PM, Stone E, Wang Y, et al. (2005) Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J Cell Biol 171: 61-73.
23. Thorp E, Li G, Seimon TA, Kuriakose G, Ron D, et al. (2009) Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP. Cell Metab 9: 474-481.
24. Erbay E, Babaev VR, Mayers JR, Makowski L, Charles KN, et al. (2009) Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med 15: 1383-1391.
25. Oh J, Riek AE, Weng S, Petty M, Kim D, et al. (2012) Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation. J Biol Chem 287: 11629-11641.
26. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, et al. (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98: 451-459.
27. Giovannucci E, Liu Y, Hollis BW, Rimm EB, (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168: 1174-1180.
28. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, et al. (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168: 1340-1349.
29. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
30. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511.
31. Dusso AS, Brown AJ, Slatopolsky E, (2005) Vitamin D. American journal of physiology Renal physiology. 289: F8-28.
32. Holick MF, (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-371.
33. Pittas AG, Lau J, Hu FB, Dawson-Hughes B, (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017-2029.
34. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, et al. (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167: 1159-1165.
35. Oh J, Weng S, Felton SK, Bhandare S, Riek A, et al. (2009) 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 120: 687-698.
36. Szeto FL, Reardon CA, Yoon D, Wang Y, Wong KE, et al. (2012) Vitamin d receptor signaling inhibits atherosclerosis in mice. Mol Endocrinol 26: 1091-1101.
37. Bernal-Mizrachi C, Weng S, Li B, Nolte LA, Feng C, et al. (2002) Respiratory uncoupling lowers blood pressure through a leptin-dependent mechanism in genetically obese mice. Arterioscler Thromb Vasc Biol 22: 961-968.
38. Bernal-Mizrachi C, Gates AC, Weng S, Imamura T, Knutsen RH, et al. (2005) Vascular respiratory uncoupling increases blood pressure and atherosclerosis. Nature 435: 502-506.
39. Bernal-Mizrachi C, Xiaozhong L, Yin L, Knutsen RH, Howard MJ, et al. (2007) An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab 5: 91-102.
40. Bernal-Mizrachi C, Weng S, Feng C, Finck BN, Knutsen RH, et al. (2003) Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat Med 9: 1069-1075.
41. Tordjman K, Bernal-Mizrachi C, Zemany L, Weng S, Feng C, et al. (2001) PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J Clin Invest 107: 1025-1034.
42. Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, et al. (2006) ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4: 377-389.
43. Riek AE, Oh J, Sprague JE, Timpson A, de Las Fuentes L, et al. (2012) Vitamin D Suppression of Endoplasmic Reticulum Stress Promotes an Anti-Atherogenic Monocyte/Macrophage Phenotype in Type 2 Diabetic Patients. J Biol Chem 287(46): 38483-94.
44. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461.
45. Gonzalez-Navarro H, Burks DJ, Andres V, (2007) Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis. Front Biosci 12: 4439-4455.
46. Raffai RL, Loeb SM, Weisgraber KH, (2005) Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels. Arterioscler Thromb Vasc Biol 25: 436-441.
47. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, et al. (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49: 1063-1069.
48. Forman JP, Curhan GC, Taylor EN, (2008) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 52: 828-832.
49. Li YC, (2003) Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 88: 327-331.
50. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, et al. (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238.
51. Schrier RW, (2010) Aldosterone 'escape' vs 'breakthrough'. Nat Rev Nephrol 6: 61.
52. Borges AC, Feres T, Vianna LM, Paiva TB, (1999) Recovery of impaired K+ channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol. Br J Pharmacol 127: 772-778.
53. Borges AC, Feres T, Vianna LM, Paiva TB, (1999) Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension 34: 897-901.
54. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C, (2001) Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 86: 1633-1637.
55. Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM, (1998) Ultraviolet B and blood pressure. Lancet 352: 709-710.
56. Zittermann A, (2003) Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89: 552-572.
57. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ, (2008) Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 102: 1540-1544.
58. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, et al. (2006) Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29: 722-724.
59. Schmidt N, Brandsch C, Kuhne H, Thiele A, Hirche F, et al. (2012) Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PloS one 7: e35316.
60. VanderLaan PA, Reardon CA, Getz GS, (2004) Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 24: 12-22.
61. Weiss D, Kools JJ, Taylor WR, (2001) Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 103: 448-454.
62. Chobanian AV, Lichtenstein AH, Nilakhe V, Haudenschild CC, Drago R, et al. (1989) Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit. Hypertension 14: 203-209.
63. Ma Y, Wang W, Zhang J, Lu Y, Wu W, et al. (2012) Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet. PloS one 7: e35835.
64. Wilson HM, (2010) Macrophages heterogeneity in atherosclerosis- implications for therapy. J Cell Mol Med 14: 2055-2065.
65. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, et al. (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142: 481-489.
66. Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston AT, et al. (2010) Macrophage plasticity in experimental atherosclerosis. PLoS One 5: e8852.
67. Trogan E, Feig JE, Dogan S, Rothblat GH, Angeli V, et al. (2006) Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci U S A 103: 3781-3786.
68. Park YM, Febbraio M, Silverstein RL, (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 119: 136-145.
69. Nagao T, Qin C, Grosheva I, Maxfield FR, Pierini LM, (2007) Elevated cholesterol levels in the plasma membranes of macrophages inhibit migration by disrupting RhoA regulation. Arterioscler Thromb Vasc Biol 27: 1596-1602.
70. Tsukano H, Gotoh T, Endo M, Miyata K, Tazume H, et al. (2010) The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. Arterioscler Thromb Vasc Biol 30: 1925-1932.